Altretamine
Back to searchMolecule Structure
Scientific Name
Altretamine
Description of the Drug
Altretamine is an antineoplastic agent used in palliative treatment of persistent or recurrent ovarian cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00488
http://www.drugbank.ca/drugs/DB00488
Brand Name(s)
Hexalen, Hexastat
Company Owner(s)
Eisai Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4206 | |
| PharmGKB | PA164743136 | |
| Human Metabolome Database | HMDB0014631 | |
| DrugBank | DB00488 | |
| PubChem: Thomson Pharma | 14748896 | |
| PubChem | 2123 | |
| Mcule | MCULE-1605383293 | |
| NMRShiftDB | 20146930 | |
| LINCS | LSM-3492 | |
| Nikkaji | J7.067J | |
| BindingDB | 37631 | |
| EPA CompTox Dashboard | DTXSID4022579 | |
| DrugCentral | 141 | |
| ChemicalBook | CB9480937 | |
| Guide to Pharmacology | 7112 | |
| rxnorm | HEXALEN | ALTRETAMINE |
| PubChem: Drugs of the Future | 12013384 | |
| ChEBI | 24564 | |
| ZINC | ZINC000000000905 |
